Type 2 & other diabetes

Preferences for basal insulin treatments in adults with type 2 diabetes: A discrete choice experiment in France and Spain

Diabetes Obes MetabPublished Discrete choice experiment

Authors' conclusion

This study highlights the importance of administration frequency in basal insulin treatment decisions when glycemic control is held constant. Participants indicated a preference for OW injection frequency, suggesting fewer injections may reduce the burden of insulin administration. These insights support clinical consideration of less frequent injections when making T2D treatment decisions.

Study context

Population
Adults with T2D in France and Spain; basal insulin and GLP-1 RA naïve, basal insulin naïve but GLP-1 RA experienced, basal insulin experiencedcompleted survey · GLP-1 RA naïve 86 · basal insulin experienced 68
Participants
239 adults
Comparison
Preferences across basal insulin treatment attributes, incl. frequency of administration (once weekly (OW) vs once daily (OD) vs BD)
  • Francen = 166
  • Spainn = 73
Outcome
Relative importance of frequency of administration in basal insulin treatment preferences
Methodological detailstargeted literature review and qualitative interviews informing attributes, pilot interviews, hierarchical Bayesian estimation, France and Spain
  • Targeted literature review and qualitative interviews informing attributes
  • Pilot interviews
  • Hierarchical Bayesian estimation
  • France and Spain

Main finding

As reported in the abstract

Relative importance of attributes

Relative importance of frequency of administration

39%

Relative importance of next highest attribute, risk of severe hypoglycaemic event (insulin experienced rates)

21%

Further findings

Most positive impacts of OW administration

Reduction in frequency of missing doses and taking doses at prescribed time considered most positive impacts of OW

Treatment experience subgroups

Findings consistent across treatment experience groups

Original publication

Preferences for basal insulin treatments in adults with type 2 diabetes: A discrete choice experiment in France and Spain. Diabetes Obes Metab. Published 19 January 2026. doi:10.1111/dom.70422

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.